Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 5:42 AM UTC
| NCT Number | NCT06736613 |
| Recruiting Status | Recruiting |
| Condition | B-Cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 50 participants |
| Active Locations | 7 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | December 18, 2025 (Dec 18, 2025) |
As of August 31, 2026: Clinical trial NCT06736613 is currently recruiting participants. This phase2 study for b-cell lymphoma is actively seeking new participants at 7 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06736613 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 7 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06736613 was last updated Dec 18, 2025 (December 18, 2025). HelloStudys verifies this status automatically.